Urology · Salem, NJ
NPI
1174589709
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4 Bypass Rd, Suite 103
Salem, NJ, 08079
Phone (856) 339-4466
Groups this clinician bills Medicare through
Medicare paid, 2024
$418K
8,297 services
Medicare patients, 2024
664
Average age 74
Drug cost, 2024
$923K
4,463 prescriptions
Company payments, 2025
$658
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stuart M Diamond was code J0585 (injection, onabotulinumtoxina, 1 unit), 2,300 times for 11 patients. In total Stuart M Diamond billed 8,297 services in 71 codes, and Medicare paid $418K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 2,300 | 11 | $4.93 | $11K |
| 99213 Office E&M - Established | Office | 1,203 | 572 | $74.00 | $89K |
| 51798 Ultrasound - Nonspecific | Office | 920 | 543 | $9.57 | $8,801 |
| 51741 Test - Miscellaneous | Office | 448 | 321 | $10.77 | $4,826 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 243 | 32 | $139.35 | $34K |
| 81002 Clinical Chemistry | Office | 241 | 209 | $3.40 | $819 |
| 99442 Telephone Services | Office | 164 | 130 | $77.06 | $13K |
| 99204 Office E&M - New | Office | 149 | 149 | $124.57 | $19K |
| 88121 Surgical Pathology Examination | Office | 132 | 122 | $40.64 | $5,364 |
| 88342 Immunohistochemistry | Office | 129 | 118 | $28.47 | $3,673 |
| 88360 Immunohistochemistry | Office | 126 | 117 | $34.42 | $4,337 |
| 88112 Surgical Pathology Examination | Office | 120 | 111 | $21.93 | $2,631 |
| 52000 Cystourethroscopy | Office | 120 | 111 | $215.34 | $26K |
| 99214 Office E&M - Established | Office | 96 | 81 | $113.36 | $11K |
| 96402 Chemotherapy Administration | Office | 79 | 32 | $32.68 | $2,582 |
By year: 2022 $460K for 9,225 services; 2023 $475K for 8,842 services; 2024 $418K for 8,297 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 241 | 209 | $3.40 | $819 |
| 88121 Surgical Pathology Examination | 132 | 122 | $40.64 | $5,364 |
| 88342 Immunohistochemistry | 129 | 118 | $28.47 | $3,673 |
| 88360 Immunohistochemistry | 126 | 117 | $34.42 | $4,337 |
| 88112 Surgical Pathology Examination | 120 | 111 | $21.93 | $2,631 |
| G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 19 | 17 | $153.64 | $2,919 |
Medicare prescription drug claims, 2024
In 2024, the drug Stuart M Diamond prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,088 prescriptions and refills. In total Stuart M Diamond wrote 4,463 Medicare prescriptions that cost $923K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,088 | 2,300 | 314 | $20K |
| Finasteride Generic | 516 | 1,139 | 167 | $6,875 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 307 | 336 | 190 | $5,314 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 254 | 577 | 77 | $7,406 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 249 | 381 | 48 | $6,236 |
| Ciprofloxacin Hcl Generic | 189 | 189 | 132 | $673 |
| Levofloxacin Generic | 167 | 167 | 128 | $562 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 163 | 175 | 95 | $733 |
| Gemtesa Vibegron | 148 | 238 | 41 | $123K |
| Myrbetriq Mirabegron | 140 | 266 | 41 | $125K |
| Testosterone Generic | 105 | 109 | 41 | $14K |
| Oxybutynin Chloride Generic | 102 | 214 | 46 | $1,117 |
| Tolterodine Tartrate Er Tolterodine Tartrate | 96 | 178 | 36 | $11K |
| Silodosin Generic | 95 | 228 | 30 | $8,803 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 75 | 75 | 70 | $266 |
Brand drugs: 543 claims; generic drugs: 3,897 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stuart M Diamond $658 ($658 in general payments such as food, travel and fees) from 13 companies. The largest payer was Antares Pharma, Inc. with $139.
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 13 | $139 |
| Merz North America, Inc. | 1 | $133 |
| Tolmar, Inc. | 6 | $98.59 |
| Janssen Biotech, Inc. JNJ | 5 | $82.29 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $46.11 |
| Olympus America Inc. | 1 | $27.37 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $23.31 |
| Revance Therapeutics, Inc. | 1 | $20.95 |
| Abbvie Inc. ABBV | 1 | $18.92 |
| Endo USA, Inc. | 1 | $18.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.